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Amyotrophic Lateral Sclerosis (ALS)
Amber Stewart RN, BSN
ALS
• Degenerative disease of upper and 
lower motors neurons.
• Between 20,000-30,000 Americans 
currently living with the disease 
(Bellomo & Chichminski, 2015). 
• Estimated 5,000 new cases 
diagnosed each year (Bellomo & 
Chichminski, 2015). 
• Affects whites more than any other 
ethnic group in the United States 
(Rechtman, Jordan, Wagner, 
Horton, & Kaye 2015).
• Typically affects males more than 
females. Males often have a longer 
prognosis as well as those 
diagnosed younger in life, and those 
with limb onset versus bulbar onset 
(Rechtman et al, 2015). 
• Prognosis after diagnosis averages 
three to five years (Bellomo & 
Chichminski, 2015).
• Most common cause of death is 
respiratory muscle weakness 
(Gordon, 2013).
• There is no cure, only palliative 
support (Gordon, 2013).
Why should
clinicians care?
●Over the past 10 years there has been 
no progress in the time it takes for 
clinicians to recognize and diagnose ALS. 
The average time from symptom onset to 
diagnosis is still eight to 16 months. This 
delay in diagnosis delays the patient and 
caregivers’ access to critical supportive 
measures. 
●Misdiagnosis could potentially cause 
increase in suffering as unnecessary 
testing or surgeries might be performed.
●Patients receiving care for ALS from a 
multidisciplinary team report higher 
quality of life.(Williams, Fitzhenry, Grant, 
Martyn, & Kerr, 2013). 
Conclusion
Amyotrophic lateral sclerosis is a 
disease characterized by the 
demyelination of upper and lower 
motor neurons. This may start 
locally, in the arm or leg, or could 
start with bulbar presentation, but 
eventually spreads to affect the 
entire body. 
Most cases of ALS are sporadic, 
but up to 10% can have a genetic 
component. More research is needed 
in both types of ALS to help the 
medical field better understand and 
treat the disease.
There is no known cure for ALS.  
All treatment is supportive in nature 
with an important focus on a 
multidisciplinary approach to 
support patients and their families. 
Prognosis after diagnosis is most 
commonly three to five years, but 
can be longer or shorter. Getting a 
quick diagnosis and supportive 
resources in sooner has been shown 
to have better patient reports of 
quality of life as well as longer 
prognosis. 
References
PathophysiologySigns & Symptoms
• Muscle twitching, or fasciculation
• Muscle weakness
• Hyperreflexia
• Positive Babinski and Hoffman 
signs
• Emotional lability
• Usually begins in the arms in 
2/3rds of patients
• Foot drop
• Difficulty walking
• Loss of hand dexterity
• Weakness when lifting arms 
(Gordon, 2013).
• 80% present with asymmetric limb 
weakness
• 20% present with bulbar onset 
• Dysarthia
• Dysphagia
• There is no single definitive test. 
ALS is diagnosed by ruling out 
other diseases and the presenting 
signs and symptoms (Bellomo & 
Chichminski, 2015). 
Because ALS affects upper and lower 
motor neuron function, it eventually 
affects the entire body. The affected 
person may start out needing minimal 
help with activities of daily living (ADL), 
but eventually, loss of motor neuron 
function impairs body muscle movement 
to the point that the affected person is 
completely dependent on others for all 
ADLs
The most common complication 
leading to death is respiratory failure. 
Some affected by the disease may choose 
to initiate life prolonging measures such 
as placement of a PEGG or intubation and 
ventilation, but others may seek 
palliative care earlier on. Since there is 
no cure for ALS, and only one drug 
available on the market that has been 
shown to slow disease progression 
minimally, getting multiple supportive 
services into the home early has been 
proven to  provide great benefit to the 
affected person and their loved ones 
through greater quality and quantity of 
life. (Williams et al., 2013)
• Demyelination of upper and lower 
motor neurons. 
• Loss of myelinated axons in the 
lateral and anterior columns of the 
spinal cord. 
• Decrease in the size of the anterior 
horn in the spinal cord.
• Degeneration and loss of large 
motor neurons in the anterior horn 
of the spinal cord, lower cranial 
motor nuclei of the brainstem, and 
Betz cells in the motor cortex. 
• Global reduction of all neurons in 
the anterior horn.
• Reduction of neuron size as well as 
atrophy of nerve fibers in ALS.
• Large empty spaces occur near 
neurons.
• Microscopic holes , which create a 
sponge-like appearance also occur.
• Bunina bodies are found in ALS, 
these are small (3-6microns big ) 
eosinophilic inclusions that are 
found in cytoplasm of motor 
neurons. Their significance is not 
understood (Saberi, Stauffer, 
Schulte, & Ravits,  2015).
Otterbein University, Westerville, Ohio
Representation retrieved from beatalsbenefit.com (2018)
Significance of 
Pathophysiology
The implications of caring for 
someone with a life limiting and 
incurable disease shift the focus to 
supportive measures such as diet, 
respiratory therapy, home medical 
equipment, physical therapy, or 
counseling. 
Ensuring that nursing care focuses 
on comfort, aligns with the patient and 
family’s goals of care, and employs a 
multidisciplinary approach is key. 
Nurses need to use their resources and 
make referrals as appropriate. 
Nurses will also need to be vigilant 
in assessing for skin breakdown for the 
bedbound and nutritionally impaired, 
assessing for respiratory infections and 
encouraging good pulmonary habits, 
and guiding patients and family’s on 
food choices and safe swallowing 
techniques as dysphagia presents itself. 
Communication in later stages of 
ALS can become problematic for many 
patients. Coming up with creative ways 
to communicate and encouraging early 
discussions about what a person wants 
for their future care will help guide 
families and clinicians alike through the 
terminal stages of the disease.  
Implications in 
Nursing
• Superoxide dismutase-1 (SOD1) 
mutations accounts for 20% of 
familial ALS (fALS). (Saberi et al, 
2015)
• SOD1 has deposition of 
ubiquitinated TDP-43 negative 
SOD1 proteins in neurons of cells
(Gordon, 2013).
• SOD1 has younger average age for 
onset, predominately starts in the 
legs with lower motor neuron 
disturbances, and has low 
occurrence of cognitive 
disturbances (Gordon, 2013). 
• TARDBP mutations account for 5% 
of fALS cases (Gordon, 2013).
• TARDBP gene causes TDP-43 
positive inclusions in the brain 
which leads to defects in RNA 
processing (Gordon, 2013).
• Whites with TARDBP often have 
onset of ALS in the arm while 
Asians with this mutation often 
have bulbar onset and longer 
disease duration (Gordon,2013).
• FUS mutations make up 5% of 
fALS, and affects amino acids in the 
FUS gene (Gordon, 2013).
• FUD mutations lead to onset of ALS 
at ages less than 40 in one third of 
the cases, typically present in the 
arms, and survival time is typically 
less than two years (Gordon, 2013).
• c9ORF72 is the most frequently 
occurring gene mutation in fALS, 
accounting for up 40% of cases
(Gordon, 2013).
• TDP-43 accumulation in the brain 
and deposits of p62 show up 
predominately in c9ORF72 
(Gordon, 2013).
Familial ALS
• Reactive astrocytes display 
increased immunoreactivity for the 
proteins GFAP and S100B. They 
express inflammatory markers, like 
COX -2, neuronal NOS (Saberi et al, 
2015).
• Microglia are activated in response 
to neuronal distress and release 
proinflammatory cytokines and 
reactive oxygen species as a result 
(Saberi et al, 2015).
• Ubiquitin, a dense, round structure 
found in the cytoplasm of neurons 
in the anterior horn cells, is 
indicative of ALS (Saberi et al, 
2015).
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Pathophysiology Continued
• TDP-43 is a ribonucleic protein that 
stabilizes mRNA, and assists with its 
processing, transport, and 
translocation (Saberi et al, 2015).
• In those with ALS, there is a loss of 
function in TDP-43 and noted 
formation of pathological 
aggregates, like ubiquitin, in the 
cytoplasm of the cells (Saberi et al, 
2015).
• The morphology of cell death in ALS 
in not clearly understood, but 
research points to cell apoptosis 
(Saberi et al, 2015).
• Axonal regrowth is inhibited by a 
pathological protein found in 
muscles fibers called  NOGO-A 
(Gordon, 2013).
• Sporadic ALS occurs in 90% of all 
cases (Saberi et al, 2015)
• Increased age, cigarette smoking, 
and pesticide exposure, service in 
the first Gulf War, and high levels of 
athleticism have been linked to 
increased risk for ALS. Trauma also 
shows an associative link.  (Gordon, 
2013).
There is very little difference in disease 
signs and symptoms, progression, or 
prognosis in sporadic v. familial ALS. There 
is no cure for either variation, and all 
measures are supportive.  
Sporadic ALS
